1 |
Songthap A, Pitisuttithum P, Kaewkungwal J, et al (2009). Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers. Southeast Asian J Trop Med Public Hlth, 40, 1048-56.
|
2 |
Department of Health UK (DOH); accessible at: http:// webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/ en/Publichealth/Immunisation/Keyvaccineinformation/ DH_104010#_1
|
3 |
Gottvall M, Larsson M, Hoglund AT, Tyden T (2009). High HPV vaccine acceptance despite low awareness among Swedish upper secondary school students. Eur J Contracept Reprod Hlth Care, 14, 399-405.
DOI
ScienceOn
|
4 |
Hajjaj AA, Senok AC, Al-Mahmeed AE, et al (2006). Human papillomavirus infection among women attending health facilities in the Kingdom of Bahrain. Saudi Med J, 27, 487-91.
|
5 |
Health Authority Abu Dhabi website [online] available at: http://www.haad.ae/haad/ar/tabid/1214/Default.aspx.
|
6 |
Hilton S, Hunt K, Bedford H, Petticrew M (2011). School nurses' experiences of delivering the UK HPV vaccination programme in its first year. BMC Infect Dis, 24, 226.
|
7 |
International Agency for Research on Cancer (IACR)-WHO-(online) available at: http://globocan.iarc.fr/
|
8 |
Keating KM, Brewer NT, Gottlieb SL, et al (2008). Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Hlth, 43, 61-7
DOI
ScienceOn
|
9 |
Kjaer SK, Breugelmans G, Munk C, et al (2008). Populationbased prevalence, type-and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer, 123, 1864-70.
DOI
ScienceOn
|
10 |
Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
DOI
ScienceOn
|
11 |
Nganwai P, Truadpon P, Inpa C, et al (2008). Knowledge, attitudes and practices vis-a-vis cervical cancer among registered nurses at the Faculty of Medicine, Khon Kaen University, Thailand. Asian Pac J Cancer Prev, 9, 15-8.
|
12 |
Nooyi SC, Al-Lawati JA (2011). Cancer incidence in Oman, 1998-2006. Asian Pac J Cancer Prev, 12, 1735-8.
|
13 |
NS Al-Nuimi, YS Alghas, AH Al-owia, J Svhnieder (2011). Human Papillomavirus vaccination uptake and factors related to uptake in a traditional desert city in UAE. Int J STD AIDS, 22, 400-4.
DOI
ScienceOn
|
14 |
Perkins RB, Clark JA (2012). What affects human papillomavirus vaccination rates? A qualitative analysis of providers' perceptions. Womens Hlth Iss, 22, 379-86.
DOI
ScienceOn
|
15 |
Al-Nuaimi NS, Al-Ghas YS, Al-Owais AH, et al (2011). Human papillomavirus vaccination uptake and factors related to uptake in a traditional desert city in the United Arab Emirates. Int J STD AIDS, 22, 400-4.
DOI
ScienceOn
|
16 |
Phianmongkhol Y, Suwan N, Srisomboon J, Kietpeerakool C (2011). Knowledge about human papillomavirus infection and cervical cancer prevention among nurses in Chiang Mai University Hospital, Thailand. Asian Pac J Cancer Prev, 12, 823-5.
|
17 |
Reiter PL, Stubbs B, Panozzo CA, Whitesell D, Brewer NT (2011). HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff. Cancer Epidemiol Biomarkers Prev, 20, 2354-61.
DOI
ScienceOn
|
18 |
Schiffman M, Castle PE (2003). Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med, 127, 930-4.
|
19 |
Badrinath P, Ghazal-Aswad S, Osman N, Deemas E, McIlvenny S (2004). A study of knowledge, attitude, and practice of cervical screening among female primary care physicians in the United Arab Emirates. Health Care Women Int, 25, 663-70.
DOI
ScienceOn
|